1. Home
  2. MDWD vs FOA Comparison

MDWD vs FOA Comparison

Compare MDWD & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$17.14

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Logo Finance of America Companies Inc.

FOA

Finance of America Companies Inc.

HOLD

Current Price

$21.97

Market Cap

183.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDWD
FOA
Founded
2000
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
224.6M
183.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MDWD
FOA
Price
$17.14
$21.97
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$37.50
$29.75
AVG Volume (30 Days)
115.3K
75.2K
Earning Date
03-18-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,932,000.00
$318,296,000.00
Revenue This Year
$6.97
$29.44
Revenue Next Year
$23.59
$14.30
P/E Ratio
N/A
N/A
Revenue Growth
6.15
N/A
52 Week Low
$14.14
$16.58
52 Week High
$22.51
$29.58

Technical Indicators

Market Signals
Indicator
MDWD
FOA
Relative Strength Index (RSI) 44.65 38.26
Support Level $16.97 $20.94
Resistance Level $18.16 $22.31
Average True Range (ATR) 0.72 0.81
MACD -0.04 -0.19
Stochastic Oscillator 17.05 25.55

Price Performance

Historical Comparison
MDWD
FOA

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About FOA Finance of America Companies Inc.

Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.

Share on Social Networks: